CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

167 hedge funds and large institutions have $1.65B invested in Celldex Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 64 increasing their positions, 52 reducing their positions, and 30 closing their positions.

Holders
167
Holders Change
-12
Holders Change %
-6.7%
% of All Funds
2.64%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
20
Increased
64
Reduced
52
Closed
30
Calls
$72.7M
Puts
$39.3M
Net Calls
+$33.4M
Net Calls Change
-$18.7M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$120M
2
Viking Global Investors
2
Viking Global Investors
Connecticut
$62.9M
3
Morgan Stanley
3
Morgan Stanley
New York
$34.7M
4
KCM
4
Kynam Capital Management
New Jersey
$25.6M
5
TLP
5
Tri Locum Partners
New York
$13.1M

Top Sellers

1
RI
1
RTW Investments
New York
$105M
2
OM
2
Opaleye Management
Massachusetts
$6.66M
3
CAC
3
Cowen and Company
New York
$0
4
FAM
4
Fred Alger Management
New York
$5.31M
5
SI
5
Sofinnova Investments
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$239M 7,010,253 +10,673 +0.2%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$120M 3,529,840 +1,343,864 +61%
RI
3
RTW Investments
New York
$105M 3,084,215 -837,364 -21%
BlackRock
4
BlackRock
New York
$104M 3,046,822 -54,208 -2%
State Street
5
State Street
Massachusetts
$91.4M 2,682,728 +314,688 +13%
Vanguard Group
6
Vanguard Group
Pennsylvania
$82.9M 2,433,595 +20,539 +0.9%
RCM
7
RA Capital Management
Massachusetts
$70.7M 2,075,000 +270,205 +15%
RG
8
Redmile Group
California
$69.7M 2,046,269 -119,317 -6%
Viking Global Investors
9
Viking Global Investors
Connecticut
$62.9M 1,846,647 +1,088,766 +144%
EAM
10
Eventide Asset Management
Massachusetts
$49.2M 1,445,700 +206,800 +17%
Citadel Advisors
11
Citadel Advisors
Florida
$38.7M 1,135,113 +65,757 +6%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$35.9M 1,054,325 +138,717 +15%
Morgan Stanley
13
Morgan Stanley
New York
$34.7M 1,019,024 +713,091 +233%
VA
14
VR Adviser
New York
$29.5M 865,116 – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$29.1M 855,513 +45,093 +6%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$27.2M 800,000 +150,000 +23%
OCA
17
Octagon Capital Advisors
New York
$25.9M 761,398 – –
KCM
18
Kynam Capital Management
New Jersey
$25.6M 753,034 +526,308 +232%
EP
19
Eversept Partners
New York
$21.7M 636,453 +43,975 +7%
VC
20
Vivo Capital
California
$21.4M 628,356 +143,903 +30%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$20.2M 592,358 +142,761 +32%
WP
22
Woodline Partners
California
$19.7M 579,192 +319,297 +123%
IC
23
Ikarian Capital
Texas
$18.3M 537,958 +118,742 +28%
Northern Trust
24
Northern Trust
Illinois
$15M 439,534 -24,630 -5%
O
25
OrbiMed
New York
$13.8M 406,100 – –
1
2 3 4 5